Showing results (1061-1070 of 1,142) with videos related to

Sort By:
Pageof 115
Scientific Reports|March 26, 2026
Dysferlin stabilizes membrane nanodomains of cardiomyocytes after myocardial infarctionJustus B Wegener, Yannik Zühlke, Carolin Fleischhacker, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
Low Prevalence of HEV Infection and No Associated Risk of HEV Transmission from Mother to Child among Pregnant Women in VietnamPham Xuan Huy, Dang Thanh Chung, Dang Thuy Linh, et al.
Journal of Hepatology|April 29, 2023
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis deltaJulius Hollnberger, Yang Liu, Simin Xu, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Zeitschrift Fur Gastroenterologie|November 8, 2021
[Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease]Niels Teich, Clara Ludewig, Renate Schmelz, et al.
Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
The Lancet. Gastroenterology & Hepatology|October 3, 2018
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studiesMarjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
Open Forum Infectious Diseases|March 6, 2025
Hepatitis E Virus Infection in Vietnamese Pregnant Women with Hepatitis B: Prevalence and Clinical OutcomesLe Thi Hong Van, Hoang Van Tong, Bui Thanh Thuyet, et al.
The Lancet. Infectious Diseases|December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 studyKatja Deterding, Christoph D Spinner, Eckart Schott, et al.
Pageof 115